keyword
https://read.qxmd.com/read/38609117/periocular-high-risk-bccs-after-additional-parallel-intake-of-torasemide-moxonidine-and-mirabegron-important-links-to-skin-cancer-related-photo-nitrosogenesis-in-the-context-of-pharmaco-oncogenesis
#1
JOURNAL ARTICLE
G Tchernev, D Dimova
The Nitrosogenesis of skin cancer is a modern newly introduced concept in medicine, mainly concerning melanoma, but also keratinocytic cancers such as basal cell carcinoma. The nitroso-contamination of more than 300 drugs worldwide and the permanent (relatively short-term) intake of mutagen-contaminated drugs could create serious prerequisites for the development of skin cancer. Retrospective but also prospective analyses following potentially contaminated polymedication with a heterogeneous type of nitrosamines in real patients are indicative of a causal connection rather than a sporadic association between 1) intake of a possibly nitrosamine-contaminated drug and 2) generation of keratinocytic skin cancer...
February 2024: Georgian Medical News
https://read.qxmd.com/read/38501595/four-week-inhibition-of-the-renin-angiotensin-system-in-spontaneously-hypertensive-rats-results-in-persistently-lower-blood-pressure-with-reduced-kidney-renin-and-changes-in-expression-of-relevant-gene-networks
#2
JOURNAL ARTICLE
Sean G Byars, Priscilla Prestes, Vara Suphapimol, Fumihiko Takeuchi, Nathan De Vries, Michelle C Maier, Mariana Melo, David Balding, Nilesh Samani, Andrew M Allen, Norihiro Kato, Jennifer L Wilkinson-Berka, Fadi Charchar, Stephen B Harrap
AIMS: Prevention of human hypertension is an important challenge and has been achieved in experimental models. Brief treatment with renin-angiotensin system (RAS) inhibitors permanently reduces the genetic hypertension of the spontaneously hypertensive rat (SHR). The kidney is involved in this fascinating phenomenon, but relevant changes in gene expression are unknown. METHODS: In SHR, we studied the effect of treatment between 10 and 14 weeks of age with the angiotensin receptor blocker, losartan, or the angiotensin-converting enzyme (ACE) inhibitor, perindopril (with controls for non-specific effects of lowering BP) on differential RNA expression, DNA methylation and renin immunolabelling in the kidney at 20 weeks of age...
March 19, 2024: Cardiovascular Research
https://read.qxmd.com/read/38493697/pharmacological-inhibition-of-the-ace-ang-2-at1-axis-alleviates-mechanical-ventilation-induced-pulmonary-fibrosis
#3
JOURNAL ARTICLE
Jinhua Feng, Xi Huang, Qiaoyi Xu, Ri Tang, Yang Zhou, Shaojie Qin, Shunpeng Xing, Yuan Gao, Shuya Mei, Zhengyu He
Mechanical ventilation (MV) is an essential therapy for acute respiratory distress syndrome (ARDS) and pulmonary fibrosis. However, it can also induce mechanical ventilation-induced pulmonary fibrosis (MVPF) and the underlying mechanism remains unknown. Based on a mouse model of MVPF, the present study aimed to explore the role of the angiotensin-converting enzyme/angiotensin II/angiotensin type 1 receptor (ACE/Ang-2/AT1R) axis in the process of MVPF. In addition, recombinant angiotensin-converting enzyme 2(rACE2), AT1R inhibitor valsartan, AGTR1-directed shRNA and ACE inhibitor perindopril were applied to verify the effect of inhibiting ACE/Ang-2/AT1R axis in the treatment of MVPF...
March 16, 2024: International Immunopharmacology
https://read.qxmd.com/read/38417334/integrated-transcriptomic-and-metabolomic-analyses-reveal-potential-regulatory-pathways-regulating-bone-metabolism-pre-and-postsexual-maturity-in-hens
#4
JOURNAL ARTICLE
Qiaoxian Yue, Chenxuan Huang, Rongyan Zhou, Yinlang Zhang, Dehe Wang, Zhenhong Zhang, Hui Chen
At the onset of sexual maturity, the increasing circulating estrogen stimulates the formation of medullary bone, which provides available calcium for eggshell formation. The bone loss of laying hens is caused by the continuous dynamic changes of structure bone leading to bone fragility and susceptibility. The degree of medullary bone mineralization in sexual maturity is positively correlated with bone quality in the late laying stage. This study aimed to explore the molecular regulation mechanism of bone metabolism pre- and postsexual maturity in hens based on the joint analysis of transcriptome and metabolome...
February 15, 2024: Poultry Science
https://read.qxmd.com/read/38399287/simultaneously-predicting-the-pharmacokinetics-of-ces1-metabolized-drugs-and-their-metabolites-using-physiologically-based-pharmacokinetic-model-in-cirrhosis-subjects
#5
JOURNAL ARTICLE
Xin Luo, Zexin Zhang, Ruijing Mu, Guangyu Hu, Li Liu, Xiaodong Liu
Hepatic carboxylesterase 1 (CES1) metabolizes numerous prodrugs into active ingredients or direct-acting drugs into inactive metabolites. We aimed to develop a semi-physiologically based pharmacokinetic (semi-PBPK) model to simultaneously predict the pharmacokinetics of CES1 substrates and their active metabolites in liver cirrhosis (LC) patients. Six prodrugs (enalapril, benazepril, cilazapril, temocapril, perindopril and oseltamivir) and three direct-acting drugs (flumazenil, pethidine and remimazolam) were selected...
February 5, 2024: Pharmaceutics
https://read.qxmd.com/read/38357670/ibrutinib-induced-pulmonary-angiotensin-converting-enzyme-activation-promotes-atrial-fibrillation-in-rats
#6
JOURNAL ARTICLE
Sen Yan, Wei Xu, Ning Fang, Luyifei Li, Ning Yang, Xinbo Zhao, Hongting Hao, Yun Zhang, Qian Liang, Zhiqi Wang, Yu Duan, Song Zhang, Yongtai Gong, Yue Li
The molecular mechanism of ibrutinib-induced atrial fibrillation (AF) remains unclear. We here demonstrate that treating rats with ibrutinib for 4 weeks resulted in the development of inducible AF, left atrial enlargement, atrial fibrosis, and downregulation of connexin expression, which were associated with C-terminal Src kinase (CSK) inhibition and Src activation. Ibrutinib upregulated angiotensin-converting enzyme (ACE) protein expression in human pulmonary microvascular endothelial cells (HPMECs) by inhibiting the PI3K-AKT pathway, subsequently increasing circulating angiotensin II (Ang II) levels...
February 16, 2024: IScience
https://read.qxmd.com/read/38332533/renal-drug-dosage-adjustments-and-adverse-drug-events-in-patients-with-chronic-kidney-disease-admitted-to-the-hospital-a-cross-sectional-study
#7
JOURNAL ARTICLE
Zuzana Očovská, Jana Procházková, Martina Maříková, Jiří Vlček
BACKGROUND: The study aimed to evaluate the agreement of prescribed drug dosages with renal dosing recommendations and describe adverse drug events (ADEs) contributing to hospital admissions of patients with chronic kidney disease (CKD). METHODS: This cross-sectional study focused on CKD patients admitted to University Hospital Hradec Králové, with an estimated glomerular filtration rate below 60 ml/min. The necessity for renal dosage adjustments was determined using the Summary of Product Characteristics (SmPC)...
February 8, 2024: Expert Opinion on Drug Safety
https://read.qxmd.com/read/38291599/legacy-benefits-of-blood-pressure-treatment-on-cardiovascular-events-are-primarily-mediated-by-improved-blood-pressure-variability-the-ascot-trial
#8
JOURNAL ARTICLE
Ajay Gupta, William N Whiteley, Thomas Godec, Somayeh Rostamian, Cono Ariti, Judith Mackay, Andrew Whitehouse, Leila Janani, Neil R Poulter, Peter S Sever
BACKGROUND AND AIMS: Visit-to-visit systolic blood pressure variability (BPV) is an important predictor of cardiovascular (CV) outcomes. The long-term effect of a period of blood pressure (BP) control, but with differential BPV, is uncertain. Morbidity and mortality follow-up of UK participants in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure-Lowering Arm has been extended for up to 21 years to determine the CV impact of mean systolic blood pressure (SBP) control and BPV during the trial, and amongst those allocated to amlodipine- and atenolol-based treatment...
January 31, 2024: European Heart Journal
https://read.qxmd.com/read/38236117/melanoma-and-dysplastic-nevi-development-after-ranitidine-rilmenidine-%C3%B0-oxonidine-lercanidipine-rosuvastatin-and-verapamil-trandolapril-new-data-case-series-the-potential-role-of-nitrosamine-ndsris-contamination-in-polymedication-as-substantial-skin-cancer
#9
JOURNAL ARTICLE
G Tchernev, N Naydekova
The idea of drug-induced/exogenic Nitrosogenesis is driven by the possibility of prolonged exposure of the human body to the influence of nitrosamines within the drug intake - substances or contaminants that have been proven to be carcinogenic or mutagenic one.Until recently, there was a complete lack of data in the scientific literature on the relationship between cancer, polymedication and polycontamination with nitrosamines. In the last decade, melanoma has been described repeatedly in the medical literature as a possible side-effect within the intake of possibly with nitrosamines contaminated medications such as: Valsartan, Hydrochlorothiazide, Amlodipine, Nebivolol, Bisoprolol and Perindopril...
November 2023: Georgian Medical News
https://read.qxmd.com/read/38228033/effects-of-telmisartan-on-metabolic-syndrome-components-a-comprehensive-review
#10
REVIEW
Mohsen Imenshahidi, Ali Roohbakhsh, Hossein Hosseinzadeh
Telmisartan is an antagonist of the angiotensin II receptor used in the management of hypertension (alone or in combination with other antihypertensive agents. It belongs to the drug class of angiotensin II receptor blockers (ARBs). Among drugs of this class, telmisartan shows particular pharmacologic properties, including a longer half-life than any other angiotensin II receptor blockers that bring higher and persistent antihypertensive activity. In hypertensive patients, telmisartan has superior efficacy than other antihypertensive drugs (losartan, valsartan, ramipril, atenolol, and perindopril) in controlling blood pressure, especially towards the end of the dosing interval...
February 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38223870/perindopril-indapamide-induced-photosensitivity
#11
JOURNAL ARTICLE
Chaker Ben Salem, Dhouha Sahnoun, Hanen Zayani, Roudha Slim, Mohamed Denguezli
No abstract text is available yet for this article.
February 2024: Hospital Pharmacy
https://read.qxmd.com/read/38200077/clinical-and-preclinical-evidence-that-angiotensin-converting-enzyme-inhibitors-and-angiotensin-receptor-blockers-prevent-diabetic-peripheral-neuropathy
#12
JOURNAL ARTICLE
Shiori Iwane, Wataru Nemoto, Tomoyoshi Miyamoto, Tomonori Hayashi, Masayuki Tanaka, Kazuki Uchitani, Tatsuya Muranaka, Masanori Fujitani, Yuichi Koizumi, Atsushi Hirata, Maho Tsubota, Fumiko Sekiguchi, Koichi Tan-No, Atsufumi Kawabata
Given possible involvement of the central and peripheral angiotensin system in pain processing, we conducted clinical and preclinical studies to test whether pharmacological inhibition of the angiotensin system would prevent diabetic peripheral neuropathy (DPN) accompanying type 2 diabetes mellitus (T2DM). In the preclinical study, the nociceptive sensitivity was determined in leptin-deficient ob/ob mice, a T2DM model. A clinical retrospective cohort study was conducted, using the medical records of T2DM patients receiving antihypertensives at three hospitals for nearly a decade...
January 10, 2024: Scientific Reports
https://read.qxmd.com/read/38158114/chymase-independent-vascular-ang-1-12-ang-ii-pathway-and-txa-2-generation-are-involved-in-endothelial-dysfunction-in-the-murine-model-of-heart-failure
#13
JOURNAL ARTICLE
Tasnim Mohaissen, Agnieszka Kij, Anna Bar, Brygida Marczyk, Kamila Wojnar-Lason, Elżbieta Buczek, Agnieszka Karas, Ana B Garcia-Redondo, Ana M Briones, Stefan Chlopicki
The angiotensin (Ang)-(1-12)/II pathway contributes to cardiac pathology. However, its involvement in the development of peripheral endothelial dysfunction associated with heart failure (HF) remains unknown. Therefore, this study aimed to characterise the effect of exogenous Ang-(1-12) and its conversion to Ang II on endothelial function using the murine model of HF (Tgαq*44 mice), focusing on the role of chymase and vascular-derived thromboxane A2 (TXA2 ). Ex vivo myographic assessments of isolated aorta showed impaired endothelium-dependent vasodilation in late-stage HF in 12-month-old Tgαq*44 mice...
December 27, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/38096536/metastatic-nodular-melanoma-developing-on-nevus-spilus-during-intake-of-beta-blockers-bisoprolol-nebivolol-and-ace-inhibitors-perindopril-potential-links-t%C3%B0-the-drug-related-nitrosogenesis-carcinogenesis-dunning-kruger-effect-and-genetic-weapons-of-the-new
#14
JOURNAL ARTICLE
G Tchernev
Drug-induced Nitrosogenesis/Carcinogenesis turns out to be a ubiquitous, pervasive, large-scale, poorly controllable concept for the academic community, which underlies the long-term, permanent modification of the human genome by contact with nitrosamines/NDSRIs, which ultimately leads to the generation of diverse cancers, but also melanoma in particular. The discovery of a (currently) unclassifiable number of nitroso derivatives/genome modifiers in the most commonly distributed drugs worldwide (in about 300 preparations according to the FDA/includes beta blockers/bisoprolol/nebivolol and ACE inhibitors/perindopril), their forced tolerability, attributed as a necessity or lack of alternative also to the present (but also to future periods), and their proven carcinogenicity (already 70 years ago), suggest a kind of creepy form of experiment to which public health is subjected worldwide...
October 2023: Georgian Medical News
https://read.qxmd.com/read/38088116/-efficacy-and-organoprotection-of-triple-combinations-in-the-treatment-of-arterial-hypertension
#15
JOURNAL ARTICLE
E V Serdechnaya
The 2022 draft Russian guidelines on arterial hypertension recommend initiation of antihypertensive therapy with a combination of drugs in most patients with blood pressure above 150 / 90 mm Hg and / or in the presence of high-risk criteria. In 2021, the results of a 12-year analysis of the Brisighella Heart Study (BHS) were published. The aim of this study was to compare the use of different triple antihypertensive drug combinations in an Italian cohort of patients in real-life clinical practice...
December 5, 2023: Kardiologiia
https://read.qxmd.com/read/38078460/the-association-between-ace-inhibitors-and-psoriasis-based-on-the-drug-targeted-mendelian-randomization-and-real-world-pharmacovigilance-analyses
#16
JOURNAL ARTICLE
Qiubai Jin, Feihong Ren, Ping Song
BACKGROUND: Although a growing number of observational studies suggest that angiotensin-converting enzyme inhibitors (ACEIs) intake may be a risk factor for psoriasis, evidence is still insufficient to draw definitive conclusions. RESEARCH DESIGN AND METHODS: Drug-targeted Mendelian randomization (DTMR) was used to analyze the causality between genetic proxied ACEIs and psoriasis. Furthermore, we performed a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database to identify more suspicious subclasses of ACEIs...
December 11, 2023: Expert Review of Clinical Pharmacology
https://read.qxmd.com/read/38065251/effect-of-angiotensin-converting-enzyme-inhibitor-and-angiotensin-receptor-blocker-on-oxidative-stress-and-metabolism-of-elements-in-kidney-of-stz-induced-diabetic-rats
#17
JOURNAL ARTICLE
Nural Pastacı Özsobacı, Metehan Karataş, Matem Tuncdemir, Dervis Özcelik
In diabetes, increased oxidative stress and impaired trace element metabolism play an important role in the pathogenesis of diabetic nephropathy. The objective of this research was to examine the outcomes of blocking the renin-angiotensin system, using either the angiotensin-converting enzyme inhibitor (ACEI), perindopril, or the angiotensin II type 1 (AT1) receptor blocker, irbesartan, on oxidative stress and trace element levels such as Zn, Mg, Cu, and Fe in the kidneys of diabetic rats that had been induced with streptozotocin...
December 6, 2023: Archives of Biochemistry and Biophysics
https://read.qxmd.com/read/37886230/preliminary-consequences-of-blood-pressure-management-and-blood-homocysteine-levels-with-perindopril-in-newly-diagnosed-hypertensive-patients-in-the-vietnamese-population
#18
JOURNAL ARTICLE
Son Kim Tran, An Bao Truong, Phi Hoang Nguyen, Toan Hoang Ngo, Tuyen Long Vu, Khoa Dang Dang Tran, Phuong Minh Vo, Bao The Nguyen, Tuong Le Trong Huynh, Kien Trung Nguyen, Hung Do Tran
BACKGROUND: Perindopril is an ACE inhibitor that aids in both blood pressure regulation and homocysteine reduction. OBJECTIVES: Our study aimed to evaluate the results of controlling blood pressure and blood homocysteine levels by perindopril in patients with primary hypertension. MATERIALS AND METHODS: A cross-sectional descriptive study with a longitudinal follow-up was conducted on 105 primary hypertensive patients treated with perindopril...
2023: International Journal of Hypertension
https://read.qxmd.com/read/37864626/a-retrospective-observational-real-word-analysis-of-the-adherence-healthcare-resource-consumption-and-costs-in-patients-treated-with-bisoprolol-perindopril-as-single-pill-or-free-combination
#19
JOURNAL ARTICLE
Stefano Masi, Zhanna Kobalava, Chiara Veronesi, Elisa Giacomini, Luca Degli Esposti, Konstantinos Tsioufis
INTRODUCTION: The present real-world analysis aims to compare the drug utilization, hospitalizations and direct healthcare costs related to the use of single-pill combination (SPC) or free-equivalent combination (FEC) of perindopril and bisoprolol (PER/BIS) in a large Italian population. METHODS: This observational retrospective analysis was based on administrative databases covering approximately 7 million subjects across Italy. All adult subjects receiving PER/BIS as SPC or FEC between January 2017-June 2020 were included...
October 21, 2023: Advances in Therapy
https://read.qxmd.com/read/37862321/ace-i-d-genotype-associates-with-strength-in-sarcopenic-men-but-not-with-response-to-ace-inhibitor-therapy-in-older-adults-with-sarcopenia-results-from-the-lace-trial
#20
JOURNAL ARTICLE
Christos Rossios, Tufail Bashir, Marcus Achison, Simon Adamson, Asangaedem Akpan, Terry Aspray, Alison Avenell, Margaret M Band, Louise A Burton, Vera Cvoro, Peter T Donnan, Gordon W Duncan, Jacob George, Adam L Gordon, Celia L Gregson, Adrian Hapca, Cheryl Hume, Thomas A Jackson, Simon Kerr, Alixe Kilgour, Tahir Masud, Andrew McKenzie, Emma McKenzie, Harnish Patel, Kristina Pilvinyte, Helen C Roberts, Avan A Sayer, Karen T Smith, Roy L Soiza, Claire J Steves, Allan D Struthers, Divya Tiwari, Julie Whitney, Miles D Witham, Paul R Kemp
BACKGROUND: Angiotensin II (AII), has been suggested to promote muscle loss. Reducing AII synthesis, by inhibiting angiotensin converting enzyme (ACE) activity has been proposed as a method to inhibit muscle loss. The LACE clinical trial was designed to determine whether ACE inhibition would reduce further muscle loss in individuals with sarcopenia but suffered from low recruitment and returned a negative result. Polymorphic variation in the ACE promoter (I/D alleles) has been associated with differences in ACE activity and muscle physiology in a range of clinical conditions...
2023: PloS One
keyword
keyword
16394
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.